PROMOTE A HEALTHIER LIFE FOR HUMANKIND THROUGH ADVANCEMENTS IN SCIENCE.
BENEFIT THE PATIENTS WITH HIGH-QUALITY MEDICATION AS WE DETERMINED TO INNOVATE.
BUILD A LEADING GLOBAL BIOPHARMACEUTICAL GROUP TO SERVE MORE.
FULFILL SOCIAL RESPONSIBILITIES THROUGH ACCOUNTABLE ACTIONS.
新闻速递
2026 AACR口头报告︱G22恒峰医药阿得贝利单抗围术期治疗可切除II-IIIB期非小细胞肺癌III期研究结果重磅亮相
焦点新闻
G22恒峰医药成为香港特区政府引进办重点企业
创立于
全球员工
1类创新药
2类新药
SH 600276
HK 1276
关于我们
投资者关系
人才发展,了解更多